With opioid overdoses surging, harm-reduction groups are calling on the FDA to change naloxone’s prescription-only status. This would make it easier to get the lifesaving drug to people at risk. Read the Full Article.
Recent Posts
- New NJACTS Publication
- The New Rutgers School of Medicine Releases Mission, Vision and Values Statement Focused on Advancing Health Equity.
- Screen Time Is a Poor Predictor of Suicide Risk, Rutger Researchers Find.
- NJIT Robotics Expert Talks Drones as the University Researches Them.
- Rutgers Health Forms Corps to Clear the Air About Asthma.
Categories
- News (2,321)
- Publication (1)